26.59
+0.77
+(2.98%)
At close: April 11 at 4:00:01 PM EDT
26.59
0.00
(0.00%)
After hours: April 11 at 4:00:10 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 12 | 12 |
| Avg. Estimate | -0.41 | -0.4 | -1.61 | -2 |
| Low Estimate | -0.66 | -0.59 | -2.36 | -3.09 |
| High Estimate | -0.2 | -0.15 | -0.55 | -0.2 |
| Year Ago EPS | -0.61 | -0.23 | -1.02 | -1.61 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 15 | 15 |
| Avg. Estimate | 86.45M | 88.57M | 360.01M | 392.51M |
| Low Estimate | 83M | 85M | 343.5M | 360.95M |
| High Estimate | 92.2M | 93.8M | 379.63M | 449.26M |
| Year Ago Sales | 88.08M | 75.4M | 310.2M | 360.01M |
| Sales Growth (year/est) | -1.85% | 17.47% | 16.06% | 9.03% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.38 | -0.52 | -0.34 | -0.2 |
| EPS Actual | -0.61 | -0.23 | 0.17 | -0.47 |
| Difference | -0.24 | 0.29 | 0.51 | -0.27 |
| Surprise % | -62.69% | 55.81% | 150.16% | -132.40% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.41 | -0.4 | -1.61 | -2 |
| 7 Days Ago | -0.4 | -0.39 | -1.63 | -2.05 |
| 30 Days Ago | -0.4 | -0.39 | -1.63 | -2.05 |
| 60 Days Ago | -0.24 | -0.26 | -1.5 | -2.11 |
| 90 Days Ago | -0.24 | -0.27 | -1.53 | -2.17 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 2 | 1 |
| Up Last 30 Days | 2 | 2 | 6 | 5 |
| Down Last 7 Days | 2 | -- | 2 | -- |
| Down Last 30 Days | 5 | 5 | 10 | 5 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IMCR | 32.94% | -72.32% | -57.38% | -24.70% |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 4/10/2025 |
| Maintains | Mizuho: Neutral to Neutral | 4/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/12/2025 |
| Reiterates | Needham: Buy to Buy | 3/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/5/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/28/2025 |
Related Tickers
NUVL Nuvalent, Inc.
66.29
+6.94%
IMTX Immatics N.V.
4.1400
+4.28%
ACLX Arcellx, Inc.
59.15
+4.39%
KYMR Kymera Therapeutics, Inc.
24.12
+7.68%
IDYA IDEAYA Biosciences, Inc.
16.75
+6.21%
XNCR Xencor, Inc.
8.54
+7.83%
XENE Xenon Pharmaceuticals Inc.
31.40
+2.18%
REPL Replimune Group, Inc.
7.35
+6.21%
NRIX Nurix Therapeutics, Inc.
9.14
+3.75%
MRUS Merus N.V.
41.97
+8.67%